Re:cognition Health Limited

Re:cognition Health Limited is a London-based holding company, active since its founding fifteen years ago in 2009. Employing seventy-four people and boasting assets of £14,880,455, the company operates from a real address in New Cavendish Street. It's led by three directors and owned by Dent Thompson Smith and Macsweeney Josephine Emir. The company regularly imports and exports optical and medical tools and devices, with recent activity recorded in January 2025 for imports and October 2024 for exports.

The company's website reveals a focus on specialist mental healthcare and clinical trials. It offers new medications for Alzheimer's at its private UK clinics and provides industry partnerships and expert opinions. Clinical trials are a key element, with the company actively seeking volunteers for life-changing research. The site also highlights its MedicoLegal services and award-winning cognitive healthcare. A recent feature on BBC One’s “Alzheimer’s: A Turning Point?” showcased the company's work in clinical trials.

Financially, Re:cognition Health Limited shows some interesting trends. Cash reserves increased by 52%, reaching £6.4 million, while bank borrowings rose slightly to £490,000. However, net assets increased by 63%, reaching £9.4 million, suggesting an increase in equity. Creditors have increased by 69%, which could be related to increased business activity. The company’s net loss decreased from £860,000 to £2.8 million. The company’s financial statements were audited by James Cowper Kreston Audit.

The increase in liabilities, despite the increase in assets, could indicate the company is investing in growth, perhaps expanding its clinical trials or acquiring new technologies. The increase in creditors could be a result of this growth. However, the rise in bank borrowings is something to keep an eye on. Overall, Re:cognition Health Limited appears to be a financially healthy company, though it’s important to monitor its debt levels as it continues to grow.

Registered in England/Wales under the registration number 06892124, with a registered address at W1G 8TA, England, London, 62-64 New Cavendish Street.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.